KAYA
|
KAYA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -63.32 | 63.89 | -98.91 | -89.15 | -52.69 |
| CEPS(Rs) | -26.60 | 3.26 | 6.27 | -17.58 | 13.75 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | -103.80 | -106.61 | -174.93 | -81.58 | -2.17 |
| Tax Rate(%) | - | - | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -4.48 | 9.04 | 15.08 | 3.73 | 8.32 |
| EBIT Margin(%) | -26.29 | -0.44 | -32.34 | -19.84 | -14.57 |
| Pre Tax Margin(%) | -43.23 | -15.36 | -45.68 | -30.86 | -20.98 |
| PAT Margin (%) | -43.23 | -15.36 | -45.68 | -30.86 | -20.98 |
| Cash Profit Margin (%) | -18.16 | 1.97 | 3.99 | -6.10 | 5.55 |
| Performance Ratios | |||||
| ROA(%) | -37.37 | -12.54 | -28.17 | -31.81 | -18.64 |
| ROE(%) | - | - | - | - | -263.21 |
| ROCE(%) | -776.46 | - | - | -121.62 | -53.94 |
| Asset Turnover(x) | 0.86 | 0.82 | 0.62 | 1.03 | 0.89 |
| Sales/Fixed Asset(x) | 0.84 | 0.67 | 0.45 | 0.81 | 0.76 |
| Working Capital/Sales(x) | -2.22 | -2.85 | -1.11 | -3.55 | -3.59 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.19 | 1.49 | 2.23 | 1.24 | 1.32 |
| Receivable days | 2.18 | 5.07 | 6.64 | 3.57 | 4.02 |
| Inventory Days | 37.64 | 45.69 | 51.68 | 27.33 | 30.75 |
| Payable days | 429.39 | 763.48 | 1,305.49 | 1,177.87 | 1,829.08 |
| Valuation Parameters | |||||
| PER(x) | - | 3.65 | - | - | - |
| PCE(x) | -8.96 | 71.54 | 50.02 | -14.41 | 25.48 |
| Price/Book(x) | -2.30 | -2.19 | -1.79 | -3.10 | -161.21 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.35 | 2.04 | 2.78 | 1.11 | 1.60 |
| EV/Core EBITDA(x) | -414.33 | 12.06 | 16.01 | 22.59 | 13.37 |
| EV/EBIT(x) | -8.95 | -459.80 | -8.58 | -5.60 | -10.98 |
| EV/CE(x) | 50.09 | 95.82 | -11.62 | 10.93 | 6.12 |
| M Cap / Sales | 1.63 | 1.41 | 2.00 | 0.88 | 1.41 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.44 | 5.84 | -45.54 | 16.29 | 17.82 |
| Core EBITDA Growth(%) | -103.44 | 3.14 | 91.73 | -52.11 | -7.17 |
| EBIT Growth(%) | -5,979.90 | 98.55 | 11.23 | -58.39 | -156.16 |
| PAT Growth(%) | -188.22 | 64.40 | 19.38 | -71.08 | -81.66 |
| EPS Growth(%) | -199.12 | 164.59 | -10.95 | -69.19 | -81.09 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | -1.04 | -1.03 | -0.78 | -1.33 | -30.33 |
| Current Ratio(x) | 0.42 | 0.46 | 0.36 | 0.57 | 0.54 |
| Quick Ratio(x) | 0.30 | 0.28 | 0.26 | 0.45 | 0.40 |
| Interest Cover(x) | -1.55 | -0.03 | -2.42 | -1.80 | -2.27 |
| Total Debt/Mcap(x) | 0.45 | 0.47 | 0.43 | 0.43 | 0.19 |
Compare Financial Ratios of peers of KAYA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KAYA | ₹481.1 Cr | -2.1% | -5.7% | -26.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹117,019.0 Cr | -8.6% | -8.2% | 13.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹90,488.6 Cr | -11.3% | -8.8% | -13.2% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹60,633.5 Cr | -9.4% | -8% | 16.3% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,995.9 Cr | -12.6% | -15.4% | -14.8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,639.9 Cr | -4.5% | -6% | 4.8% | Stock Analytics | |
KAYA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KAYA | -2.1% |
-5.7% |
-26.1% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses
